The Medwatch panel: Is Denmark falling behind as an entrepreneurial country?
Is the lack of risk capital and the high tax burden in Denmark undercutting innovation in the country’s biotech industry – or is it just a myth? This week’s Medwatch panel of three top-execs and one politician offer their opinions on the matter.
Louise Reseke
According to a survey published at the world’s largest biotech convention in Boston earlier this year, the US is the only country more favorable than Denmark for setting up a biotech cluster.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
